Bernhard Janke

Bernhard Janke is a Partner at 468 Capital, a venture capital firm located in Berlin and San Francisco, since October 2021. In addition, Janke has taken on various investment roles with multiple companies, including Zellerfeld Shoe Company Inc., Cartken, ParcelBio, Tamarind Bio, Relari, YonedaLabs, Velorum Therapeutics, ego, and acto, all starting in April or February 2024. Janke holds a Master’s Degree in Industrial Engineering from the Karlsruhe Institute of Technology, obtained in 2013, and a Bachelor’s Degree in the same field from the same institution, completed in 2011.